Location: Stockholm, Sweden
CIK: 0001599882 · Show all filings
Period: Q1 2015 (← Previous) (Next →)
Filing Date: May 13, 2015
Total Value: $593M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SELECT SECTOR SPDR TR | 440,000 | $31.9M | 5.4% | — | — | Put | 81369Y961 |
| — | Alexion Pharmaceuticals Inc | 114,978 | $19.93M | 3.4% | $161.94 | — | COM | 015351109 |
| — | Celgene Corp | 151,000 | $17.41M | 2.9% | $113.27 | — | COM | 151020104 |
| MRK | Merck & Co Inc | 300,000 | $17.24M | 2.9% | $38.32 | +5.2% | COM | 58933Y105 |
| BIIB | Biogen Inc | 40,700 | $17.18M | 2.9% | $335.29 | +17.6% | COM | 09062X103 |
| AMGN | Amgen Inc | 99,000 | $15.82M | 2.7% | $108.83 | +5.7% | COM | 031162100 |
| ALKS | Alkermes Plc | 258,000 | $15.73M | 2.7% | $53.58 | +27.5% | SHS | G01767105 |
| GILD | Gilead Sciences Inc | 159,000 | $15.6M | 2.6% | $64.85 | +8.8% | COM | 375558103 |
| UNH | United Health Group Inc | 130,000 | $15.38M | 2.6% | $81.05 | +15.0% | COM | 91324P102 |
| CVS | CVS Health Corp | 145,000 | $14.96M | 2.5% | $60.39 | +23.0% | COM | 126650100 |
| — | Actavis Plc | 45,300 | $13.48M | 2.3% | $258.48 | — | SHS | G0083B108 |
| ABBV | AbbVie Inc | 220,000 | $12.88M | 2.2% | $37.18 | +4.5% | COM | 00287Y109 |
| CAH | Cardinal Health Inc | 141,400 | $12.76M | 2.2% | $57.37 | +10.9% | COM | 14149Y108 |
| ESPR | Esperion Therapeutics Inc | 126,926 | $11.75M | 2.0% | $22.47 | +187.2% | COM | 29664W105 |
| — | Rite Aid Corp | 1,276,462 | $11.09M | 1.9% | $6.53 | — | COM | 767754104 |
| INCY | Incyte Corp Ltd | 120,000 | $11M | 1.9% | $69.98 | +18.1% | COM | 45337C102 |
| — | Nektar Therapeutics | 996,600 | $10.96M | 1.8% | $11.22 | — | COM | 640268108 |
| UHS | Universal Health Services Inc B | 87,000 | $10.24M | 1.7% | $105.74 | 0.0% | COM | 913903100 |
| REGN | Regeneron Pharmaceuticals Inc | 22,000 | $9.933M | 1.7% | $334.35 | +26.1% | COM | 75886F107 |
| JAZZ | Jazz Pharmaceuticals Plc | 55,000 | $9.503M | 1.6% | $167.61 | +2.4% | SHS | G50871105 |
| LLY | Eli Lilly & Co | 129,000 | $9.372M | 1.6% | $53.64 | +9.3% | COM | 532457108 |
| BMRN | BioMarin Pharmaceutical Inc | 75,000 | $9.347M | 1.6% | $76.23 | +39.0% | COM | 09061G101 |
| — | Medivation Inc | 69,000 | $8.906M | 1.5% | $80.67 | — | COM | 58501N101 |
| — | Anthem Inc | 57,000 | $8.801M | 1.5% | $154.40 | — | COM | 36752103 |
| MCK | McKesson Corp | 38,000 | $8.596M | 1.4% | $181.90 | +12.3% | COM | 58155Q103 |
| BMY | Bristol Myers Squibb Co | 129,000 | $8.321M | 1.4% | $35.96 | +20.8% | COM | 110122108 |
| — | Receptos Inc | 43,500 | $7.173M | 1.2% | $122.51 | — | COM | 756207106 |
| — | Valeant Pharm Intl Inc | 36,000 | $7.15M | 1.2% | $198.61 | — | COM | 91911K102 |
| — | Cyberonics Inc | 108,000 | $7.011M | 1.2% | $64.95 | — | COM | 23251P102 |
| VRTX | Vertex Pharmaceuticals Inc | 58,000 | $6.842M | 1.2% | $87.26 | +37.3% | COM | 92532F100 |
| — | Becton Dickinson & Co | 46,982 | $6.746M | 1.1% | $143.59 | — | COM | 75887109 |
| — | Orexigen Therapeutics Inc | 831,800 | $6.513M | 1.1% | $6.65 | — | COM | 686164104 |
| — | Isis Pharmaceuticals Inc | 102,000 | $6.494M | 1.1% | $52.32 | — | COM | 464330109 |
| — | Intercept Pharmaceuticals Inc | 23,000 | $6.486M | 1.1% | $226.71 | — | COM | 45845P108 |
| — | Cempra Inc | 185,300 | $6.358M | 1.1% | $34.31 | — | COM | 15130J109 |
| CYH | Community Health Syst Inc | 118,000 | $6.169M | 1.0% | $37.22 | +11.2% | COM | 203668108 |
| ACAD | Acadia Pharmaceuticals Inc | 171,000 | $5.573M | 0.9% | $24.02 | +43.1% | COM | 004225108 |
| HCA | HCA Holdings Inc | 74,000 | $5.567M | 0.9% | $53.97 | +23.7% | COM | 40412C101 |
| ALNY | Alnylam Pharmaceuticals Inc | 53,000 | $5.534M | 0.9% | $90.65 | +11.8% | COM | 02043Q107 |
| SUPN | Supernus Pharmaceuticals Inc | 450,800 | $5.45M | 0.9% | $8.32 | +13.5% | COM | 868459108 |
| — | Medtronic Plc | 69,000 | $5.381M | 0.9% | $64.46 | — | COM | 585055106 |
| — | Laboratory Corp of America Hgs | 39,000 | $4.918M | 0.8% | $126.10 | — | COM | 50540R409 |
| — | Revance Therapeutics Inc | 236,000 | $4.892M | 0.8% | $24.34 | — | COM | 761330109 |
| — | Cerner Corp | 66,000 | $4.835M | 0.8% | $61.35 | — | COM | 156782104 |
| DXCM | Dexcom Inc | 77,000 | $4.8M | 0.8% | $9.43 | +60.2% | COM | 252131107 |
| — | Amsurg Corp | 76,000 | $4.676M | 0.8% | $53.11 | — | COM | 03232P405 |
| — | Tetraphase Pharmaceuticals Inc | 122,000 | $4.47M | 0.8% | $36.64 | — | COM | 88165N105 |
| — | Intra-Cellular Therapies Inc | 183,000 | $4.37M | 0.7% | $17.63 | — | COM | 46116X101 |
| — | Aetna Inc | 41,000 | $4.368M | 0.7% | $89.12 | — | COM | 00817Y108 |
| COR | AmerisourceBergen Corp | 38,000 | $4.319M | 0.7% | $51.53 | +43.5% | COM | 03073E105 |
| — | Clovis Oncology Inc | 54,000 | $4.008M | 0.7% | $46.26 | — | COM | 189464100 |
| — | Abiomed Inc | 55,000 | $3.937M | 0.7% | $26.15 | — | COM | 003654100 |
| — | Omnicare Inc | 50,000 | $3.853M | 0.6% | $72.47 | — | COM | 681904108 |
| — | Keryx Biopharmaceuticals Inc | 297,000 | $3.781M | 0.6% | $12.80 | — | COM | 492515101 |
| — | Thoratec Corp | 87,000 | $3.644M | 0.6% | $31.71 | — | COM | 885175307 |
| — | Rigel Pharmaceuticals Inc | 1,000,000 | $3.57M | 0.6% | $3.57 | — | COM | 766559603 |
| CNC | Centene Corp | 48,000 | $3.393M | 0.6% | $21.33 | +41.0% | COM | 15135B101 |
| HOLX | Hologic Inc | 101,000 | $3.336M | 0.6% | $24.29 | +26.4% | COM | 436440101 |
| MGNX | Macrogenics Inc | 106,000 | $3.325M | 0.6% | $27.09 | +25.1% | COM | 556099109 |
| — | Celldex Therapeutics Inc | 119,000 | $3.317M | 0.6% | $19.03 | — | COM | 15117B103 |
| — | Endologix Inc | 194,000 | $3.312M | 0.6% | $14.71 | — | COM | 29266S106 |
| PRGO | Perrigo Co Plc | 20,000 | $3.311M | 0.6% | $159.50 | 0.0% | SHS | G97822103 |
| — | St Jude Medical Inc | 48,800 | $3.192M | 0.5% | $62.72 | — | COM | 790849103 |
| — | Ariad Pharmaceuticals Inc | 387,000 | $3.189M | 0.5% | $6.55 | — | COM | 04033A100 |
| — | Anthera Pharmaceuticals Inc | 701,314 | $3.135M | 0.5% | $3.59 | — | COM | 03674U201 |
| TEVA | Teva Pharma Ind Ltd ADR repr 1 Share | 50,000 | $3.115M | 0.5% | $62.30 | — | COM | 881624209 |
| — | Tesaro Inc | 52,999 | $3.042M | 0.5% | $31.85 | — | COM | 881569107 |
| LGND | Ligand Pharmaceuticals Inc B | 39,000 | $3.007M | 0.5% | $33.38 | +14.8% | COM | 53220K504 |
| PODD | Insulet Corp | 90,000 | $3.002M | 0.5% | $35.95 | -6.1% | COM | 45784P101 |
| — | Cepheid Inc | 52,000 | $2.959M | 0.5% | $47.98 | — | COM | 15670R107 |
| SYK | Stryker Corp | 32,000 | $2.952M | 0.5% | $81.99 | 0.0% | COM | 863667101 |
| — | Array BioPharma Inc | 400,000 | $2.948M | 0.5% | $4.79 | — | COM | 04269X105 |
| XNCR | Xencor Inc | 190,000 | $2.911M | 0.5% | $14.68 | +7.5% | COM | 98401F105 |
| — | Heartware Intl Inc | 33,000 | $2.896M | 0.5% | $87.76 | — | COM | 422368AA8 |
| OMCL | Omnicell Inc | 80,000 | $2.808M | 0.5% | $32.97 | 0.0% | COM | 68213N109 |
| — | Achillion Pharmaceuticals Inc | 280,000 | $2.761M | 0.5% | $9.71 | — | COM | 00448Q201 |
| — | Dynavax Technologies Corp | 122,835 | $2.755M | 0.5% | $1.96 | — | COM | 268158102 |
| EW | Edwards Lifesciences Corp | 19,000 | $2.707M | 0.5% | $11.54 | +94.4% | COM | 28176E108 |
| — | Tandem Diabetes Care Inc | 209,000 | $2.638M | 0.4% | $12.69 | — | COM | 875372104 |
| — | Kite Pharma Inc | 45,000 | $2.596M | 0.4% | $57.66 | — | COM | 49803L109 |
| — | Endo International Plc | 26,741 | $2.399M | 0.4% | $89.71 | — | SHS | G30401106 |
| — | Celladon Corp | 120,053 | $2.274M | 0.4% | $11.46 | — | COM | 15117E107 |
| MYGN | Myriad Genetics Inc | 60,000 | $2.124M | 0.4% | $35.53 | +0.7% | COM | 62855J104 |
| — | Avalanche Biotechnologies Inc | 43,000 | $1.742M | 0.3% | $40.51 | — | COM | 05337G107 |
| — | Lexicon Pharmaceuticals Inc | 1,594,805 | $1.506M | 0.3% | $1.07 | — | COM | 528872104 |
| — | Mirati Therapeutics Inc | 45,388 | $1.331M | 0.2% | $29.32 | — | COM | 60468t105 |
| — | Threshold Pharmaceuticals | 201,537 | $818K | 0.1% | $4.08 | — | COM | 885807206 |
| — | BIND Therapeutics Inc | 133,535 | $733K | 0.1% | $11.18 | — | COM | 05548N107 |
| — | Chimerix Inc | 14,200 | $535K | 0.1% | $37.68 | — | COM | 16934W106 |